About AVT
Browse Articles
Authors
Customer Services

Advanced Publication

Antiviral Therapy publishes articles here before they are finally assigned to an issue. The articles are listed by online publication date and can be cited via a doi.
 
Displaying 24 results:

Original article

Long-term outcomes in Chinese patients with chronic hepatitis B receiving nucleoside/nucleotide analogue therapy in real-world clinical practice: 5-year results from the EVOLVE study

Jidong Jia1*, Jia Shang2, Hong Tang3, Jiaji Jiang4, Qin Ning5, Xiaoguang Dou6, Shuqin Zhang7, Mingxiang Zhang8, Tao Han9, Deming Tan10, Xinmin Zhou11, Guoliang Chen12, Jifang Sheng13, Zhijun Su14, Haijun Chen15, Erhei Dai16, Yinong Ye17, Ying Guo18, Yuefei Shen19, Jing Yuan20, Zhen Wei21, Siyun Zhu22, the EVOLVE Study Group

10.3851/IMP3372


Original article

Recording of HIV viral loads and viral suppression in South African patients receiving antiretroviral treatment: a multicentre cohort study

Tameryn Pillay, Morna Cornell, Matthew P Fox, Jonathan Euvrard, Geoffrey Fatti, Karl-Günter Technau, Nosisa Sipambo, Hans Prozesky, Brian Eley, Frank Tanser, Leigh F Johnson

10.3851/IMP3371


Original article

Efficacy of elbasvir/grazoprevir therapy in HCV genotype-1 with or without HIV infection: role of HCV core antigen monitoring and improvement of liver stiffness and steatosis

Maneerat Chayanupatkul, Salyavit Chittmittraprap, Pornpitra Pratedrat, Natthaya Chuaypen, Anchalee Avihingsanon, Pisit Tangkijvanich

10.3851/IMP3370


Original article

Baseline resistance-associated substitutions may impact DAA response among treatment failure chronic hepatitis C patients with pegylated interferon and ribavirin in real life

Shan Ren, Feili Wei, Yi Jin, Junfeng Lu, Zhimin He, Lina Ma, Yanhong Zheng, Junli Wang, Xinyue Chen

10.3851/IMP3369


Free
Short communication

Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system

Michael A Jarvis, Frederick A Hansen, Kyle Rosenke, Elaine Haddock, Christopher Rollinson, Simon Rule, Graham Sewell, Andrew Hughes, Heinz Feldmann

10.3851/IMP3368


Original article

Hepatitis B core-related antigen levels predict pegylated interferon-α therapy response in HBeAg-positive chronic hepatitis B

Boris JB Beudeker, Zwier MA Groothuismink, Robert A de Man, Harry LA Janssen, Annemiek A van der Eijk, Andre Boonstra, Milan J Sonneveld

10.3851/IMP3367


Original article

Dynamics of HBV surface antigen related endpoints in chronic hepatitis B infection: a systematic review and meta-analysis

Yusi Chen, Justin Jinhui Li, Rong Chen, Gailing Li, Jia Ji

10.3851/IMP3366


Free
Commentary

SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection

Elise J Smolders, Lindsey HM te Brake, David M Burger

10.3851/IMP3365


Review

The effects of nucleoside/nucleotide analogues on host immune cells: the baseline for future immune therapy for HBV?

Lauke L Boeijen, Michelle Spaan, André Boonstra

10.3851/IMP3364


Original article

Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjects

Maribel Reyes, Justin D Lutz, Audrey H Lau, Anuj Gaggar, Ethan P Grant, Adarsh Joshi, Richard L Mackman, John Ling, Susanna K Tan, Natarajan Ayithan, Stephane Daffis, Jacky Woo, Peiwen Wu, Tina Lam, Simon P Fletcher, Shyamasundaran Kottilil, Bhawna Poonia, Edward J Gane, Anita Mathias, Polina German

10.3851/IMP3363


Page:
Copyright © 2020 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.